Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by wildkydon Nov 21, 2019 10:46am

90 Views

Post# 30378107

RE:Metastatic Lung Cancer

it is so sad Handkerchief. And to this that our trial isn't expected to end until May 2022...It should be over by May 2020 and onto another trial! I will complain again - the system is soooo slow. We need to get our rat test results out to the world (and into human clinical trials) And the world will be clamoring for our treatment and our shares...

Bullboard Posts

Morning Market Outlook for June 17, 2024